Breaking News

Theorem Promotes Veteran Researcher

September 10, 2013

Lake to lead respiratory biopharma franchise

Phil Lake has been appointed executive director of biopharmaceutical development, respiratory, at Theorem Clinical Research. Mr. Lake will be responsible for senior oversight on major projects as well as building the company’s respiratory business globally.
 
Mr. Lake joined Theorem as senior director of project management in 2012. He has held positions including managing director of Springfield Clinical Consulting, executive director of project management in Europe for Covance and as senior clinical research manager for GlaxoSmithKline in London. He has significant therapeutic experience in respiratory disorders, including numerous COPD and asthma studies.
 
“Phil Lake has been a tremendous asset to our European operations, and I am confident he has the contacts and experience to take our biopharmaceuticals division to the next level,” said Theorem president and chief executive officer, John Potthoff.

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016